Hair shedding is not caused by the GLP-1 itself
Eli Lilly, the manufacturer, has updated the pen to make understanding your dosing clearer
The Ideal Diet A phase 3 double-blinded, randomized clinical control trial published in 2022 that looked at the use of a GLP-1 agonist, Tirzepatide (Mounjaro ), for the treatment of obesity has paved the way for the use of GLP-1 agonists for weight loss (1)
Pack contains 30 gel capsules Keep out of sight and reach of children.
The efficacy of GLP-1 analogues on appetite parameters, gastric emptying, food preference and taste among adults with obesity: Systematic review of randomized controlled trials
Mounjaro, Ozempic, Wegovy, and Zepbound are trademarks of their respective owners, and altRx is not affiliated with the manufacturers of these brand-name medications